Go Pro
→ Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (From Altimetry) (Ad)tc pixel
LON:4BB

4basebio Interim Earnings Report

4basebio logo
GBX 485 +20.00 (+4.30%)
As of 08/21/2026 11:37 AM Eastern
ProfileEarnings HistoryForecast

4basebio EPS Results

Actual EPS
-GBX 50
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

4basebio Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

4basebio Announcement Details

Quarter
Interim
Date
9/29/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

4basebio Earnings Headlines

4basebio (LON:4BB) Shares Down 2.2% - What's Next?
August 21 at 2:01 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30973363
4basebio Plc - Grant of Options & Director/PDMR Dealing
July 22, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/4basebio-plc-grant-options-director-060000215.html
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel
August 23 at 1:00 AM  |  Chaikin Analytics (Ad)
4basebio awards new management share options to support long-term growth
July 22, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/4basebio-awards-new-management-share-options-to-support-long-term-growth?utm_source=marketbeat.com&utm_medium=referral
4basebio Plc - Director Appointment
July 8, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/4basebio-plc-director-appointment-060000656.html
4basebio strengthens board with deep tech investor Cornel Chiriac
July 8, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/4basebio-strengthens-board-with-deep-tech-investor-cornel-chiriac?utm_source=marketbeat.com&utm_medium=referral
See More 4basebio Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 4basebio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 4basebio and other key companies, straight to your email.

About 4basebio

4basebio (LON:4BB) is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients. Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.

View 4basebio Profile
Earnings Tools